PharmaBoardroom

Interview with Paul Flapper, General Manager, Shire International…

Shire has many offices in America, Europe, as well as in Singapore, in Japan and in Australia. The group has a vast global network and a strong…

Interview with Pye Sen Tan, CEO, Herbal Science

Herbal Science started in 1985 as team of two pharmacists and now represents a large 200-person operation. What have been the main challenges for the…

Interview with Viggo Birch, Managing Director UK and Vice…

This year’s Q1 results for Novo Nordisk were extremely positive with a 23% increase in profit. While this growth was mostly driven by the US and…

Interview with Dr Richard W Barker, Director General, Association…

Taking a look at a key achievement of the ABPI in recent years, we recognize the role you played in negotiating the revised PPRS that was put in place…

Interview with Professor Sir John Bell, Chair, Office for the…

It are exciting times for the UK, with the public healthcare system undergoing so many changes. The Office of Life Sciences (OLS) and the Therapeutic…

Interview with Richard Blackburn, Managing Director, Pfizer UK

As part of a panel discussion with Claudia Hammond of the BBC last year, you commented on the fairly poor relationship between the NHS and industry,…

Interview with Warwick Smith, Director, British Generic…

Together with Germany, the UK the highest generic penetration rate in Europe. Since you have been with the association since 1995 and obviously saw…

Interview with Stephen Whitehead, Chief Executive Officer,…

What are the priorities on your agenda as the new head of ABPI considering the successes and difficulties the association has experienced in the past?…

Interview with Mark Jones, Marketing Company President,…

AstraZeneca reported decrease in its global revenue for the first half of 2011 mostly due to adverse market conditions in the US. In this context, how…

Interview with Han Willems, General Manager, Promega Netherlands

Promega is a truly global company with a vast international presence. What would you say is the strategic importance that the Benelux affiliate has…

Interview with Nigel Gaymond, Chief Executive, BioIndustry…

The UK has got around half of the public biotech companies and 21% of all entrepreneurial bioscience companies in Europe. From your perspective, can…

Interview with Sheila Kelly, Chief Executive, Proprietary…

Thank you for having us today! You have been chief executive of the Association since 1990 and obviously observed the evolution of the OTC market from…

Tagged with